Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled levodopa versus oral levodopa pharmacokinetics in Parkinson's disease
NL-OMON25573Active, not recruiting
- Sponsor
- Department of Pharmaceutical Technology and Biopharmacy
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levodopa in Parkinson's disease (PD) (3 arms), sponsored by Department of Pharmaceutical Technology and Biopharmacy. Primary endpoints: Maximum levodopa plasma concentration, Time to maximum plasma concentration and 1 more. Started Jan 2016; status: active, not recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON25573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25573.